Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
Emergent Biosolutions Inc (NYSE: EBS) closed the day trading at $5.14 up 4.47% from the previous closing price of $4.92. In other words, the price has increased by $4.47 from its previous closing price. On the day, 0.84 million shares were traded. EBS stock price reached its highest trading level at $5.295 during the session, while it also had its lowest trading level at $4.94.
Ratios:
For a better understanding of EBS, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.64 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.80. For the most recent quarter (mrq), Quick Ratio is recorded 1.77 and its Current Ratio is at 3.69. In the meantime, Its Debt-to-Equity ratio is 1.40 whereas as Long-Term Debt/Eq ratio is at 1.39.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 30, 2024, initiated with a Buy rating and assigned the stock a target price of $15.
On August 22, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $16.
The Benchmark Company Upgraded its Hold to Buy on March 07, 2024, while the target price for the stock was maintained at $5.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 12 ’25 when Fowler Neal Franklin sold 35,000 shares for $5.83 per share. The transaction valued at 204,050 led to the insider holds 101,100 shares of the business.
Zoon Kathryn C sold 10,000 shares of EBS for $57,300 on Mar 12 ’25. The Director now owns 44,482 shares after completing the transaction at $5.73 per share. On Mar 12 ’25, another insider, Fowler Neal Franklin, who serves as the Director of the company, bought 35,000 shares for $5.83 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EBS now has a Market Capitalization of 279292160 and an Enterprise Value of 855892288. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.27 while its Price-to-Book (P/B) ratio in mrq is 0.58. Its current Enterprise Value per Revenue stands at 0.82 whereas that against EBITDA is 16.028.
Stock Price History:
The Beta on a monthly basis for EBS is 2.07, which has changed by 0.2914573 over the last 52 weeks, in comparison to a change of 0.09765589 over the same period for the S&P500. Over the past 52 weeks, EBS has reached a high of $15.10, while it has fallen to a 52-week low of $2.82. The 50-Day Moving Average of the stock is -6.14%, while the 200-Day Moving Average is calculated to be -38.69%.
Shares Statistics:
Over the past 3-months, EBS traded about 1.23M shares per day on average, while over the past 10 days, EBS traded about 1055720 shares per day. A total of 54.30M shares are outstanding, with a floating share count of 52.32M. Insiders hold about 3.72% of the company’s shares, while institutions hold 64.10% stake in the company. Shares short for EBS as of 1744675200 were 9024472 with a Short Ratio of 7.36, compared to 1741910400 on 9156033. Therefore, it implies a Short% of Shares Outstanding of 9024472 and a Short% of Float of 16.780001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
